• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从Dugdhāmalakyādi瑜伽发展而来的咀嚼片:一种阿育吠陀制剂。

Development of a chewable tablet from Dugdhāmalakyādi Yoga: An Ayurvedic preparation.

作者信息

Santhosh S B, Ambi Arun B, Hiremath R R, Mannur V S

机构信息

Department of Bhaishajya Kalpana, KLE's Shri BMK Ayurveda Mahavidhyalaya, Shahapur, Belgaum, Karnataka, India.

出版信息

Anc Sci Life. 2012 Jul;32(1):34-7. doi: 10.4103/0257-7941.113802.

DOI:10.4103/0257-7941.113802
PMID:23929992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3733205/
Abstract

BACKGROUND

Āmalaki (Embelica officinalis Gaertn.) is one of the most celebrated herbs in the Indian system of traditional medicine. It is one of the best Rasāyana-s (health promoting) drug. In Dugdhāmalakyādi yoga, Āmalaki (Embelica officinalis Gaertn.) powder is administered along with milk in case of svarabhaṅga (hoarseness of voice). Here an attempt is made to convert this formulation into chewable tablet without altering its property to improve its palatability, shelf life and fixation of proper therapeutic dose.

METHODOLOGY

Chewable tablets were prepared by wet granulation method. Here, Āmalaki powder was prepared initially and it was mixed with additives and preservatives. Granules were prepared from this mixture by adding binding agent, finally compressed in to tablets.

RESULTS AND CONCLUSION

The physico-chemical analysis of Āmalaki standard are: Foreign Matter-Nil, Acid insoluble Ash-0.51%w/w, Water soluble Ash-2.01% w/w, Alcoholic Extractives-44.48%, Aqueous Extractives 67.52%, pH-3.1, Moisture content-8.19%. Quality control test for chewable tablet was carried out and found satisfactory with general characteristics of tablet viz. hardness 1.8, disintegration time 15-20 min, friability 0.5%, weight variation +/- 3%. The TLC of Āmalaki powder showed 3 spots with Rf value 0.14, 0.4, and 0.73 and the chewable tablets showed 2 spots with Rf value 0.31 and 0.89 under 254 nm. The adaptation of modern techniques or methods to convert the Ayurvedic formulations without altering its therapeutic property is necessary to made them suitable for the present trends of newer drug delivery dosage forms.

摘要

背景

余甘子(Phyllanthus emblica Linn.)是印度传统医学体系中最著名的草药之一。它是最佳的rasāyana-s(促进健康)药物之一。在Dugdhāmalakyādi瑜伽中,对于声嘶(声音嘶哑),余甘子(Phyllanthus emblica Linn.)粉末与牛奶一起服用。在此,尝试将该制剂转化为咀嚼片,同时不改变其性质,以提高其适口性、保质期并固定合适的治疗剂量。

方法

采用湿法制粒法制备咀嚼片。在此,首先制备余甘子粉末,并将其与添加剂和防腐剂混合。通过加入粘合剂由该混合物制备颗粒,最后压制成片。

结果与结论

余甘子标准品的理化分析结果为:杂质-无,酸不溶性灰分-0.51%w/w,水溶性灰分-2.01%w/w,醇溶性浸出物-44.48%,水溶性浸出物67.52%,pH-3.1,水分含量-8.19%。对咀嚼片进行了质量控制测试,发现其片剂的一般特性令人满意,即硬度1.8,崩解时间15 - 20分钟,脆碎度0.5%,重量差异+/- 3%。余甘子粉末的薄层色谱在254nm下显示3个斑点,比移值分别为0.14、0.4和0.73,咀嚼片显示2个斑点,比移值分别为0.31和0.89。在不改变其治疗特性的情况下,采用现代技术或方法来转化阿育吠陀制剂,使其适合新型药物递送剂型的当前趋势是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/34e0d52a57c6/ASL-32-34-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/175c0e46bc10/ASL-32-34-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/71547c3b17db/ASL-32-34-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/e8e3700e0954/ASL-32-34-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/34e0d52a57c6/ASL-32-34-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/175c0e46bc10/ASL-32-34-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/71547c3b17db/ASL-32-34-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/e8e3700e0954/ASL-32-34-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/337e/3733205/34e0d52a57c6/ASL-32-34-g010.jpg

相似文献

1
Development of a chewable tablet from Dugdhāmalakyādi Yoga: An Ayurvedic preparation.从Dugdhāmalakyādi瑜伽发展而来的咀嚼片:一种阿育吠陀制剂。
Anc Sci Life. 2012 Jul;32(1):34-7. doi: 10.4103/0257-7941.113802.
2
Safety of chewable tablets for children.儿童咀嚼片的安全性。
J Asthma. 2002 Aug;39(5):391-403. doi: 10.1081/jas-120004032.
3
Development, optimization and characterization of chewable tablet containing synergistic combination of magnesium orotate dihydrate with cholecalciferol and menaquinone-7 for management of hyperglycemia and its pharmacokinetic study.含二水合乳清酸镁与胆钙化醇及甲萘醌-7协同组合的咀嚼片用于高血糖管理的研制、优化与表征及其药代动力学研究
Magnes Res. 2021 May 1;34(2):43-63. doi: 10.1684/mrh.2021.0487.
4
Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.多层压缩包衣片:新型可咀嚼阿莫西林/克拉维酸盐片剂配方及湿度研究
Drug Dev Ind Pharm. 1998 Aug;24(8):729-36. doi: 10.3109/03639049809082720.
5
An index for evaluating difficulty of Chewing Index for chewable tablets.咀嚼片咀嚼指数难度评价指标。
Drug Dev Ind Pharm. 2015 Feb;41(2):239-43. doi: 10.3109/03639045.2013.858736. Epub 2013 Nov 19.
6
Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers.用于治疗胃溃疡的含槲皮素固体分散体的筏状形成液体制剂和咀嚼片制剂的研发。
Saudi Pharm J. 2021 Oct;29(10):1143-1154. doi: 10.1016/j.jsps.2021.08.005. Epub 2021 Aug 9.
7
A New Approach to Enhance the Solubility of Famotidine Tablet by Using Naturally Isolated Pear Starch.一种通过使用天然分离的梨淀粉提高法莫替丁片溶解度的新方法。
Recent Pat Drug Deliv Formul. 2018;12(1):75-80. doi: 10.2174/1872211312666180105113037.
8
Formulation development of sugar free antacid chewable tablets for diabetes induced acidity in patients.
Pak J Pharm Sci. 2019 Nov;32(6(Supplementary)):2811-2816.
9
Formulation and Evaluation of Alstonia boonei Stem Bark Powder Tablets.博内鸡骨常山茎皮粉末片的制剂与评价
Indian J Pharm Sci. 2013 Mar;75(2):226-30.
10
Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.壳聚糖作为崩解剂对呋塞米片生物利用度的影响:新型制剂的体外评价与体内模拟
Pak J Pharm Sci. 2012 Oct;25(4):815-22.

本文引用的文献

1
Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients.诃子对HIV感染患者常见分离菌株的生长抑制活性评估。
Phytother Res. 2007 May;21(5):476-80. doi: 10.1002/ptr.2105.
2
Hypolipidemic effect of triphala in experimentally induced hypercholesteremic rats.三果木对实验性诱导的高胆固醇血症大鼠的降血脂作用。
Yakugaku Zasshi. 2007 Feb;127(2):385-8. doi: 10.1248/yakushi.127.385.
3
Influence of amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats.
余甘子(余甘子Gaertn.)对高胆固醇饮食喂养大鼠高胆固醇血症和脂质过氧化的影响。
J Nutr Sci Vitaminol (Tokyo). 2005 Dec;51(6):413-8. doi: 10.3177/jnsv.51.413.
4
Radioprotection of Swiss albino mice by Emblica officinalis.余甘子对瑞士白化小鼠的辐射防护作用。
Phytother Res. 2005 May;19(5):444-6. doi: 10.1002/ptr.1600.
5
Chemopreventive action of emblica officinalis on skin carcinogenesis in mice.余甘子对小鼠皮肤致癌作用的化学预防作用。
Asian Pac J Cancer Prev. 2005 Apr-Jun;6(2):197-201.
6
Immunomodulatory activity of triphala on neutrophil functions.三果汤对中性粒细胞功能的免疫调节活性。
Biol Pharm Bull. 2005 Aug;28(8):1398-403. doi: 10.1248/bpb.28.1398.
7
Antioxidant activity of DHC-1, an herbal formulation, in experimentally-induced cardiac and renal damage.
Phytother Res. 2005 Mar;19(3):216-21. doi: 10.1002/ptr.1659.
8
Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn.余甘子的解热和镇痛活性评估
J Ethnopharmacol. 2004 Nov;95(1):83-5. doi: 10.1016/j.jep.2004.06.020.
9
Antiproliferative activity of the main constituents from Phyllanthus emblica.余甘子主要成分的抗增殖活性。
Biol Pharm Bull. 2004 Feb;27(2):251-5. doi: 10.1248/bpb.27.251.
10
Antitussive activity of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae).余甘子(大戟科)果实提取物的镇咳活性。
Phytomedicine. 2003;10(6-7):583-9. doi: 10.1078/094471103322331872.